durvalumab
astrazeneca
['pivotal', 'topaz-1', 'astrazeneca']
 2022 updates: presented the results for patient-reported outcomes and pre-planned secondary objectives from the pivotal topaz-1 trial at the #asco 2022 annual meeting. learn more: #asco #asco22 #asco2022 #oncology #oncologist #cancer 
#DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the healthcare industry